Categories
Cannabis Events Press Releases

Earth Science Tech LTD (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)

DORAL, Florida, Dec. 11, 2018 (GLOBE NEWSWIRE)

Earth Science Tech LTD. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that as the Company is now an “OTC reporting issuer” in the Province of Québec, Canada, its board of directors is considering a dual listing of its common shares on the Canadian Securities Exchange (CSE).

Earth Science intends to file an application with the CSE in early 2019. Listing could happen as early as in the third quarter of the Company’s current fiscal year and would require certain regulatory approvals that would allow Earth Science to market and sell its common shares to Canadian investors.

“The Canadian Securities Exchange has seen significant increases in trading, particularly in the cannabis and CBD space. We feel that by listing on the two exchanges we will attract more investors in both the U.S. and Canada, creating further liquidity and increasing our ability to raise capital in a different market. With our R&D operations conducted in Canada and our CEO residing in Canada, considering a listing on the CSE makes the most sense,” states Earth Science president, director and Chairman Nickolas S. Tabraue.

Categories
Cannabinoids Cannabis Events Cannabis Oils Feature Story Marketing Science Uncategorized

A Guide to Cannabinoids – The Science, The Synergy and its Role in Society

People today are more eager than ever to take a more active role in their overall health and wellness. The recent spike in popularity for cannabis and cannabinoid-rich products is a reflection of this movement- one that has led many to want to cultivate a more intentional relationship with this healing herb.

In the last several years there’s been a big spotlight placed on cannabis. It seems as though this medicinal plant is finally getting the recognition it deserves for the many health benefits it offers.  As cannabinoids become one of the most sought-after natural products on the market, we see consumers eager to ask more questions on a personal quest to learn as much as they can about the topic. For this reason, a helpful guide to cannabinoids can assist in educating and clarifying some of the finer points relating to the science of, and the synergy between cannabinoids, as well as some broader questions pertaining to its current place in modern society.

Let’s get started…

The Science-

Cannabinoids affect many important functions in the endocannabinoid system in our bodies. CBD for instance has pain relieving, antioxidant, anti-inflammatory and anti-nausea effects, while CBN has been shown to act as a sedative, and is helpful in managing anxiety, while CBC has antibiotic, antifungal, anti-inflammatory properties and helps relieve pain and so on. There has been extensive research regarding the internal interplay when cannabinoids, flavonoids, terpenes and fatty acids all work in concert to abate symptoms of pain, inflammation, depression, anxiety, fungal, bacterial infections and more.

Each cannabinoid has a different and beneficial effect in our body. Here are some of the more common ones along with their specific function:

  • Cannabinol (CBN): sedative, antibiotic, anticonvulsant, and anti-inflammatory.
  • Cannabidiol (CBD): anticonvulsant, antioxidant, reduces anxiety, treats psychotic disorders, relieves pain, reduces inflammation, and relieves spasms
  • Tetrahydrocannabinol (THC) ; antioxidant, anti-inflammatory, induces a euphoric high, relieves pain
  • Cannabigerol (CBG): antibiotic, anti-fungal, anti-inflammatory, and relieves pain
  • Cannabichromene (CBC): antibiotic, anti-fungal, anti-inflammatory, and relieves pain.
  • Tetrahydrocannabivarin (THCV): induces a euphoric high and relieves anxiety.

 

But how does it work?…

Cannabinoids have a profound and positive impact on the body’s own receptor system. Scientists are still trying to figure out exactly how those chemical compounds interact with each other and within the human body. Although there is increasing evidence that there may be more types, today we know about two receptors: CB1 and CB2. These receptors are distributed on the surface of many different types of cells in the body. CB1 receptors are found primarily on neurons in the brain- like in the amygdala, which influence emotions such as fear and anxiety. A high density of CB1 receptors are also found in the hippocampus, those influence the learning and absorption of new information as well as memory integration. As for the second class of receptor, CB2, those are more abundant in the central nervous system and in the peripheral tissues and organs, particularly in the immune system cells and thus are thought to act in a primarily protective role.

-The Synergy-

Medicinal plants like cannabis contain a wide variety of potentially beneficial compounds. Choosing between full-spectrum and isolate-type products is an important choice when deciding what products to start using. In full-spectrum phytocannabinoid products, the “whole-plant” is used and nothing is held back or left out. That is because whole-plant or FULL-SPECTRUM products are known to include not just CBD but trace amounts of different cannabinoids which introduce various potential benefits that can address a wide variety of ailments both on their own and in conjunction with one another. An isolate is of course effective but studies show that full spectrum CBD is capable of offering greater levels of relief. That is because full-spectrum oils include a wide range of cannabinoids which work synergistically. People seem to respond better to products which contain multiple cannabinoids opposed to single cannabinoids in isolation. And, unsurprisingly, this finding is in line with how cannabinoids are found in nature as opposed to being produced synthetically in a lab. As we can see, when certain isolated components are combined together, they produce a greater more tangible benefit to the user—and this interaction actually has a name, it’s known as the entourage effect.

The term entourage effect was first used decades ago by two Israeli scientists Shimon Ben-Shabat and Raphael Mechoulam upon realizing that cannabinoids found in the cannabis plant actually work in a similar way as the body’s own endocannabinoid system. Each separate cannabinoid has a different and beneficial effect in our body. While researchers agree that more studies are needed to understand the entourage effect, many can attest that the heightened efficacy when compounds operate together is real and not imagined.  Not only can this be seen between certain cannabinoids but also in how terpenes and flavonoids work synergistically increasing the cerebral blood flow while impacting the blood-brain barrier.  As research continues, our knowledge will collectively broaden. The good news is that the field is wide open for greater exploration and development.

Society-

As the popularity of hemp-derived products continue to grow, so has its acceptance across many of the states in America. Just this summer, a major step was taken to pass legislation that would legalize hemp as part of the 2018 Farm Bill. Many agree we seem to be moving in the right direction amidst the changing political landscape of today although, “Is it legal?” is still a common question. Many wish the answers were more straightforward but the reason for the current murkiness is because there are different laws in different states, as well as different laws at the state and also federal levels.

CBD oil that is hemp-derived and consists of no illegal amounts of THC is legal in most states. As of this year, there are states where the recreational and medicinal use of cannabis is also completely legal. They are Colorado, Maine, Massachusetts, Nevada, Oregon, Washington and Alaska. That means if you live in these states, you are free to use CBD and other products without a prescription. Unfortunately, it seems as though laws are constantly in flux, which adds to the legal confusion. Hopefully, there will be more clarity and consistency coming from state and federal authorities sometime in the near future.

So the short answer to, “Is it legal?’ is, there is no short answer. You must check the local law in the state where you live- and stay up on any and all changes. If you live in a state where the recreational use of cannabis is legal, you can use CBD that comes from marijuana or hemp without issue (with the exception of California and provided you are at least 21 years of age). If you live in a state where medical cannabis is legal, and you have a prescription, you are also in the clear. For everyone else in the country, the laws surrounding CBD are stuck in a temporary gray zone. Eventually, many believe that all the states in the country, even the most culturally conservative ones will submit to peoples’ demands and the growing scientific research and legalize cannabis use for medical purposes- once and for all.

Categories
Cannabinoids Cannabis Events Cannabis Oils Cannabis Plant Feature Story Hemp Oil In the News Uncategorized

Cannabinoids, CBD and One Woman’s Journey with Multiple Sclerosis – A Personal Story

Ingrid was barely 26 years old when she was first diagnosed with multiple sclerosis (MS). The first sign something was amiss came when she was on vacation in the Dominican Republic in the early 1980’s. She woke up in her hotel room with double vision- in both eyes. She walked over to the mirror but all she could see was a hazy gray cloud staring back at her. She went to a nearby clinic in Santo Domingo but they didn’t really know what to tell her. After a general exam, they asked if she had insurance back home and recommended she see a doctor as soon as she got back. She had just had her first baby and decided not to tell my parents about the incident. When she landed in Miami, with her vision back intact, she dismissed the experience as a one-off and went back to work on Monday. Six months later she was driving home from work during the tail end of rush hour. She remembers the night was warm and the flickering brake lights reminded her of the dusky, setting sun. As the traffic around her came to a stop, she placed her foot on the brake, or tried to, but her leg did not respond. She tried again. Nothing. She recalls how terrifying it was realizing she could not move her leg, it was as though her brain and body were not connecting. And she was right. She slammed into the cars in front of her but luckily no one was seriously hurt. After that incident she went to a doctor, got a spinal tap and was diagnosed with multiple sclerosis.

And that is how, on a warm summer night, her journey with MS began- as well as our family’s journey with MS. For the next two decades my sister would be in remission. She worked a full time job (took the train to work) and managed to have three more children. She just became a grandmother in her 50’s, and has a large, loving and supportive family around her. But this progressive disease finally caught up to her. She is now unable to stand on her own or bathe herself independently and spends most days in a wheelchair in front of the television.

Cannabis has been used for medicinal purposes throughout centuries and is now recommended and prescribed to manage the symptoms of multiple sclerosis and other neurodegenerative diseases. I have been researching the beneficial effects of cannabis in multiple sclerosis for years but there is still much to be done in the way of education and clinical testing. Even so, anecdotal as well as many randomized placebo-controlled clinical trials have shown the efficacy of various cannabinoid treatments in managing spasticity, pain, bladder problems, sleep disturbances and tremor due to MS.

Every case of MS is different as is every person affected. Thankfully my sister does not suffer from pain-related symptoms. She’s had two seizures though, back to back in recent years and because of them has suffered some cognitive loss as well as other progressive symptoms like tremor and incontinence. She was able to obtain a license for medical marijuana this year and was prescribed a medicine which contained some THC, the main psychoactive component of cannabis.

She accepted the recommendation of the clinician without question or doubt. However, in no time we noticed some disturbing side effects. Things like short-term memory impairment, some disruption in her psycho-motor control and a somewhat weird, and distorted sense of time. For example, in July she asked where the Christmas decorations were. Around the same time, her caretaker reported panic on my sister’s part during a routine hair-washing session. This was unlike her and was clearly not the intended result and definitely not what we expected. I felt guilt having been the one to propose the idea that she start this regiment in the first place. What did I miss? It was a big anti-climactic disappointment; we had waited months for the license and had high hopes that it would bring her some relief. But the opposite occurred- this prescribed cannabis treatment not only didn’t work, it actually made her worse.

I knew that cannabinoids mimic naturally occurring compounds in the body called endocannabinoids. Endocannabinoids have been widely studied and implicated in a variety of physiological functions specifically with MS. When we take in cannabinoids, they interact with the same receptors found in all human cells. What I didn’t fully appreciate was that THC (tetrahydrocannabinol) affects the central nervous system (CNS) through these receptors- most densely in the frontal cortex and hippocampus. Cognition, especially in certain groups, such as patients suffering from diseases of the CNS like my sister, were particularly vulnerable to adverse effects.  However, some of the other constituents of cannabis, such as CBD (cannabidiol), have well-documented biological effects like anti-anxiety and anticonvulsive properties without any of the psychotropic actions. We realized that CBD might hold greater therapeutic potential for her than THC or any combination containing THC, since the psychoactive properties that accompany THC did not agree with her at all.  

We decided to give it one more shot and take matters into our own hands. We were on the lookout for a high quality- hemp derived, Full Spectrum CBD product. We were fortunate to find RAW, a high-grade, cannabinoid oil tincture. It contains unfiltered industrial full spectrum hemp oil, coconut MCT oil, and vitamin E as well as a variety of valuable phyto-nutrients, synergistic cannabinoids and essential oils. With RAW, we hit the jackpot. Not only did it work well, but it began working almost immediately.

One of my focuses of my freelance writing in the cannabis and medicinal marijuana space was to help my sister combat her MS symptoms and to help her live a fuller life. I saw that start to happen with RAW. As someone who does consistent research on the subject, I recommend this product as well as encourage everyone to do their own research.

From my experience, and from interviewing others, I understand that the manufacturing and selling of CBD products has become big business. I now know how to discern the differences between high quality products and subpar products as well as understand the different extraction methods available. Other finer points like the question of full spectrum vs. isolate products are important to understand before making a decision.

Ingrid began using RAW in the morning and at night, taking .5ml under her tongue, twice a day. After about a week she experienced less spasticity, less fatigue and tremor, and was just more alert and lucid. We have also seen a big improvement with her MS-related urinary symptoms. Her increased sense of well-being is also visible; the other day she commented that she “felt really strong”. When she visits her daughters, we pack ETS’s new veggie capsules in her overnight bag- we find that it’s easier for her to manage when she’s traveling.

We were concerned initially how this new regiment would interact chemically with her other prescribed drugs- but so far, she’s had no issues. We are thrilled, over the moon, and grateful that we didn’t give up. And you shouldn’t either. Cannabis derived compounds can hold real potential for those looking to treat symptoms of MS. The most important points to keep in mind are quality and consistency. You need to do your research, seek out the highest quality product you can find, and stay consistent with the dosing. For those looking to try any of EST’s products, the great news is you do not need a special marijuana card or prescription to do so.

Click here find out more about ETS.

Categories
Cannabis Events In the News Latest News Press Releases Top Stories

EARTH SCIENCE TECH, INC. CELEBRATES THE END OF A YEAR OF MAJOR ACHIEVEMENTS AND LOOKS FORWARD TO A BANNER 2018

Doral, FL, Dec. 28, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or, the “Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, shares all the company’s achievements throughout 2017 and what’s to come 2018.

It would be easy to list all of the achievements of the past year, but impossible to squeeze them all into one announcement. However, there are some highlights that the company wishes to underscore as 2017 comes to a close.

“This past year was amazing,” stated Michel Aubé PhD, CEO and Chief Scientific Officer. “I am very enthusiastic about the start of the New Year with all that we accomplished in 2017. We implemented a development plan for the coming three years and opened new manufacturing and shipping facilities which position us perfectly to realize our long term vision. We have really built the foundation and infrastructure the company needs to succeed long-term. Fiscally, we began the process of up-listing from the Pink Sheet category to the OTCQB and we will complete this process early in 2018. This up-listing will bring aboard well-funded institutional investors and I feel that we are now on the way to becoming the next billion-dollar-in-capitalization company on the OTC Markets.”

At the beginning of the year, ETST finished populating its Scientific Advisory Council with a team of recognized scientists. The company also found the perfect research center to complete the development of the three nutraceuticals in ETST’s new-product pipeline and future projects.

January:

In January, Earth Science Tech signed a Marketing & Media Agreement with Pearls of Health and appointed Gabriel Aviles as Chief Sales Officer (CSO).

Since the addition of Gabriel Aviles as CSO, the growth of the market has been appreciable. New partnerships with multiple distributors of dietary supplement stores all across USA have drastically increased the company’s sales and exposure. Gabriel Aviles adds, “My team of representatives already have the best-quality, full spectrum industrial hemp oil and derived products on the market and our product offerings will become still better with the launch of the incredible products we are developing. In 2017 we nearly doubled our sales over 2016 and sales will continue to skyrocket over the few next years both in the USA alone, and in the new markets we will open in neighbouring and overseas countries.”

January also saw the launch of a chocolate product manufactured through a joint venture with Karmavore SuperFood, which was a great success, complimenting the company’s CBD line. As well signing Sergio Castillo as the company’s Chief Marketing Officer, enhancing ETST’s image and achieving successful brand exposure. The market for products derived from hemp oil is growing and ETST will continue to surprise consumers with new innovative recipes in 2018.

February:

In February the company launched Cannabis Therapeutic Inc., a new division whose purpose is to develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products using Earth Science Tech’s existing Cannabis CBD Patent, IP, and future technologies to be developed. The company engaged to create two new Cannabinoid-based pharmaceutical drugs and three new advanced Cannabinoid-based nutraceutical products in collaboration with Smart Medicine, Inc. an independent laboratory based in Le Centre Québecois d’Innovation en Biotechnologie (CQIB) in Laval, Québec

ETST also acquired Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada. This acquisition is allowing the company access to government grants offered to companies for innovation in the pharmaceutical industry. Applications for grant have already been files and the company anticipates announcing the granting of the first request in Q1 2018. The existence of this Canadian division will help extend the collaboration between ETST resources in Canada and USA, and allow the company to have up to 50% of all R&D expenditures covered by grants from governmental or private sources.

March:

In Marsh ETST commenced leasing the required manufacturing facility for the production of the MSN-2 medical device and began the first round of negotiations with foreign health authorities for the MSN-2’s commercialization. This product will be launched in select countries in 2018, which will be the beginning of the success story for this unique tool that will allow women to take their health needs in their own hands. It will allow women to protect themselves and their future babies from Chlamydia and other sexually transmitted infections (STI). ETST is proud to participate in the fight to counter the spread of STI and their devastating effects on the sexual organs of women.

April:

May:

At the end of May, ETST launched several new products, including Strawberry Orange Blossom CBD oil, CBD Organic Chocolate line, and Pet CBD oil; ETST’s management team found an opportunity to step into the recreational vape/smoke market by partnering with Varsity Group, LLC; a Kanna ingredient based e-liquid company.

June:

ETST launched it’s new wholly-owned subsidiary, KannaBidioid Inc., entering into a joint venture with Varsity Group, LLC. The new subsidiary is manufacturing and distributing vapes/e-liquids and gummy edibles to fulfill the product needs of vape/smoke shops. »

In June ETST signed an agreement with Absolu Communications, one of Canada’s most prestigious integrated web and communications companies, for the branding and rollout of ETST’s much-anticipated MSN-2 medical device. At year end, the branding – including the brand name, visual identity (logo, packaging, artwork), and marketing language around the new product are close to being announced. In 2018, Absolu will develop a secure transactional website for online sales, and then deliver a communications and marketing plan for the rollout of the new device.

August:

In august ETST signed an agreement with the Centre de Développement Bioalimentaire du Québec (CDBQ), a major force in the agro-food industry in Canada. Based in La Pocatière, Quebec, CDBQ specializes in helping companies develop the processes needed to take a prototype agro-food or nutraceutical product to industrial-scale production for the marketplace. CDBQ boasts a bio-food incubator, a 30,000 square foot $10 million facility that houses seven separate factories equipped with cutting-edge equipment and technology.

ETST signed a new partnership with Brazilian company, Bionatus. Inc., to participate in the manufacturing, distribution, and development of cannabis (CBD) products. With Bionatus, ETST is working to develop a treatment against asthma that will be unique and sold all across the USA in the near future. This market is very huge and the product will represent a new income stream.

September:

In September a strategic agreement was signed with Axcelon Biopolymers Corp. for the distribution of their Nanoderm™ medical device was signed. The agreement adds potential success to ETST’s foreign market development as – along with the MSN-2 medical device – ETST now has two medical devices to catch the eyes of foreign medical device distributors.

October:

In October ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device enters molecular diagnostic trials.

November

In November ETST began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula is based on industrial hemp CBD oil mixed with a known natural ingredient proven to help increase dopamine levels. The formula is expected to decrease cravings and the negative effects of withdrawal in addicts.

The company announced a new partnership agreement to develop the Vietnam market. Vietnam will join Djibouti and Morocco as the early launch markets for ETST medical devices while the company waits for regulatory permission to launch in North America.

The marketing efforts done in 2017 succeeded in significantly increasing the volume of sales in the USA and had a great exposure at ETST’s first expo. ETST will revamp its cannabinoids products in the beginning of 2018 to promote its full spectrum hemp oil products, which are now ready to explode on market. Everything is in place to satisfy the demands of the consumer market with it’s new major distributor.

December:

At year end, ETST has everything place to launch a Regulation A+ Tier 2 round of financing in 2018. The goal will be to raise $4 million to complete all the actual planned projects.

ETST’s president, Director, & COO ends the year with, “we have had a very successful year building ETST’s brand image, increasing exposure, building a solid team, and positioning ourselves for en explosive successful 2018. We plan on bringing three new officer positions to our growing company to increase effeminacy and continue our growth. Our audit is still being done and looks to be finalized very soon, our new product revamp is planned to launch mid-January, and our OTCB up-listing will take place along with the initiation of the regulation A+ Tier 2. We greatly appreciate all who have believed in our vision and I look forward on what 2018 has to come.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118

Categories
Cannabis Events Latest News Press Releases

Earth Science Tech Announces a Suc-cessful Two-Day SOHO Expo

ETST Corporate Brand Well Received at EXPO; Opening New Accounts, Both Retail and Wholesale

Doral, FL, Dec. 05, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, updates shareholders on the participated successful SOHO Expo, which was mentioned in early November (Earth Science Tech. Announces New Corporate Facility & participates in its First Trade Expo in December).

On December 2nd and 3rd, ETST participated at its first major show at the SOHO Expo in the Gaylord Palms Orlando Resort in Florida. “The event was a huge success, generating the additional exposure to expand the ETST territory.  We had the opportunity to open new retail and wholesale accounts, as well as speak to consumers directly to the advantages of the ETST product line,” stated Nickolas Tabraue ETST’s President, Director, & COO.

Gabriel Aviles, ETST’s Chief Sales Officer and Director shares, “On top of the countless new connections we made, thanks to the tremendous networking opportunities at the expo, we were able to directly add to our bottom line. The additional accounts we added during the expo will also create recurring revenue for us.”

Nickolas Tabraue, concludes with, “As we have been growing and evolving as a company, we have been working hard to revamp our products and develop a stronger marketing strategy. With the success we found this weekend, I would say our new developments are working. We are excited to start rolling out our CBD products across the nation, and to continue on the rapid growth trajectory we’ve set out on.”

 

About Earth Science Tech (ETST)

Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world’s best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

 

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

 

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

 

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

 

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

 

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118

Categories
Cannabis Events In the News Latest News Press Releases Top Stories

Earth Science Tech. Announces New HQ & participates on it’s First Trade Expo in December

Doral, FL, Nov. 16, 2017 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, announces new improved HQ and participates on it’s first major trade expo during December first through the third.

New HQ

ETST has relocated it’s HQ into the city of Doral centrally located by Miami International airport and major postal services headquarters. ETST’s new two story facility has seven office spaces to accommodate the growing team and a large AC’d warehouse to store ETST’s increasingly high demand inventory. Not only is the HQ large but, it has been completely remodeled to look and feel like the brand as soon as you walk in.

Earth Science Tech

Office Location:

8000 NW 31st Street

Suite 19

Doral, FL 33122

“Our new head quarters is finally complete hinted recently, https://www.globenewswire.com/news-release/2017/10/10/1143709/0/en/Earth-Science-Tech-Inc-Partners-with-Centre-SIDA-Amite-Clinic-to-Commence-Final-Pre-Launch-MSN-2-Human-Research-Study.html. We acquired the space in the beginning of September right before hurricane Irma. Due to Irma, the remodeling took more time then anticipated but, thankfully it is complete and fully operational. We plan on adding photos of our new HQ to our site very and encourage investors to come and visit.” Stated, Nickolas S. Tabraue, ETST’s President, Director, & COO.

 

SOHO EXPO

ETST plans to participate in its first major trade expo, Showing Others Healthy Options Expo (SOHO EXPO) at the GayLord Palms Hotel, Kissimmee, FL opened to qualified industry representatives. The expo is produced by Senpa, a non-profit trade association of retailers, manufacturers, distributors, brokers, educators, practitioners, and service providers that are dedicated to protecting and advancing the natural product industry.

 

ETST will be stationed booths 425 and 427 positioned in half an island located in the prime sector of the expo. A quarter of the island will be for ETST’s CBD products and the other quarter of the island for ETST’s new wholly owned subsidiary, KannaBidioiD, Inc.’s products.

 

Gabriel Aviles, ETST’s Chief Sales Officer & Director comments, “”

 

ETST continuously plans on updating its shareholders on the above-mentioned expo and R&D as further progress and development occur.

 

About Earth Science Tech (ETST)

Earth Science Tech has the highest quality, purity, and full spectrum High-Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world’s best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed alongside the University of Central Oklahoma and DV Biologics laboratory, prove we are the top nutritional and dietary supplement brand for High-Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

View ETST’s accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

 

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

 

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

 

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused on the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by it’s unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

 

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

 

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Dave Demarest (305)-546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305)-615-2118